Stocks and Investing Stocks and Investing
Mon, April 22, 2013

Matthew Harrison Maintained (VRTX) at Hold with Increased Target to $91 on, Apr 22nd, 2013


Published on 2024-10-25 02:29:27 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Increased Target from $45 to $91 on, Apr 22nd, 2013.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Debjit Chattopadhyay of "Janney Montgomery Scott" Initiated at Strong Buy and Held Target at $54 on, Wednesday, January 2nd, 2013

Contributing Sources